Loss of detectability and indeterminate results: Challenges facing HIV infant diagnosis in South Africa's expanding ART programme

South African Medical Journal

Volumn 104, Issue 8, 2014, Pages 574-577

  Haeri Mazanderani, Ahmad F ^a   du Plessis, Nicolette Marie ^b   Thomas, Winifred Nancy ^b   Venter, Elizabeth ^b   Avenant, Theunis ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Antiretroviral therapy (ART); Early infant diagnosis (EID); HIV; Prevention of mother to child transmission (PMTCT)

Indexed keywords

ABACAVIR; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR; TENOFOVIR; VIRUS RNA;

ARTICLE; CASE REPORT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE TRANSMISSION; FALSE NEGATIVE RESULT; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOTHER CHILD RELATION; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS LOAD; FEMALE; HIV INFECTIONS; INFANT; LABORATORY DIAGNOSIS; NEWBORN; SOUTH AFRICA; VERTICAL TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FALSE NEGATIVE REACTIONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POLYMERASE CHAIN REACTION; RNA, VIRAL; SOUTH AFRICA;

EID: 84905266065     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.8322     Document Type: Article

References (23)

1. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008;359(21):2233-2244. [http://dx.doi.org/10.1056/NEJMoa0800971]
2. South African National Department of Health. The South African Antiretroviral Treatment Guidelines 2013: PMTCT Guidelines. Pretoria: Department of Health, 2013. at http://web.up.ac.za/sitefiles/file/45/1335/877/ PMTCT%20guidelines_March%202013_DoH.pdf (accessed 13 May 2013).
3. South African National Department of Health. The South African Antiretroviral Treatment Guidelines 2013. Pretoria: Department of Health, 2013. http://www.doh.gov.za/docs/policy/2013/ART_Treatment_Guidelines_ Final_25March2013.pdf (accessed 11 October 2013).
4. World Health Organization. Guidelines on HIV and Infant Feeding 2010. Principles and Recommendations for Infant Feeding in the Context of HIV and a Summary of Evidence. Geneva: World Health Organization, 2010. http://www.who.int/maternal_child_adolescent/documents/9789241599535/en/ (accessed 23 December 2013).
5. The Tshwane declaration of support for breastfeeding in South Africa. South African Journal of Clinical Nutrition 2011;24(4):214.
6. Persaud D, Ray SC, Kajdas J, et al. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy. AIDS Res Hum Retroviruses 2007;23(3):381-390. [http:// dx.doi.org/10.1089/aid.2006.0175]
7. Dunn DT, Simonds RJ, Bulterys M, et al. Interventions to prevent vertical transmission of HIV-1: Effect on viral rate in early infant samples. AIDS 2000;14(10):1421-1428. [http://dx.doi.org/10.1097/00002030-200007070-00016]
8. Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants. Antivir Ther 2004;9(2):179-185.
9. Burgard M, Blanch S, Jasseron C, et al. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J Pediatr 2012;160(1):60-66. [http://dx.doi. org/10.1016/j.jpeds.2011.06.053]
10. Roche® COBAS® AmpliPrep/COBAS® TaqMan HIV-1 Qual Test [package insert]. Branchburg, NJ: Roche, 2010.
11. Stevens W, Erasmus L, Moloi M, et al. Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants. J Clin Microbiol 2008;46(12):3941-3945. [http://dx.doi.org/10.1128/JCM.00727-09]
12. Maritz J, Preiser W, van Zyl GU. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots. J Clin Virol 2012;53(2):106-109. [http://dx.doi.org/10.1016/j.jcv.2011.12.002]
13. Maritz J, van Zyl GU, Preiser W. Irreproducible positive results on the Cobas Ampliprep/Cobas TaqMan HIV-1 Qual Test are different qualitatively from confirmed positive results. J Med Virol 2014;86(1):82-87. [http:// dx.doi.org/10.1002/jmv.23811]
14. Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med 2013;369(19):1828-1835. [http://dx.doi.org/10.1056/NEJMoa1302976]
15. Meintjes H, Hall K. Demography of South Africa's children. In: Hall K, Woolard I, Lake L, et al., eds. South African Child Gauge 2012. Cape Town: Children's Institute, University of Cape Town, 2012:82-85. http://www. ci.org.za/index.php?option=com_content&view=article&id=997&Itemid=399 (accessed 12 June 2013).
16. Haeri Mazanderani AF, du Plessis NM, Lumb J, et al. Recommendations for the medical evaluation of children prior to adoption in South Africa. S Afr Med J 2014;104(8):544-549. [http://dx.doi.org/10.7196/SAMJ.7958]
17. Connolly MD, Rutstein RM, Lowenthal ED. Virologic testing in infants with perinatal exposure to HIV receiving multidrug prophylaxis. Pediatr Infect Dis J 2013;32(2):196-197. [http://dx.doi.org/10.1097/ INF.0b013e3182787c29]zvh
18. Lilian RR, Kalk E, Bhowan K, et al. Early diagnosis of in uteroand intrapartum HIV infection in infants prior to 6 weeks of age. J Clin Microbiol 2012;50(7):2373-7237. [http://dx.doi.org/10.1128/JCM.00431-12]
19. World Health Organization. WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children. Geneva: WHO, 2010. http://whqlibdoc.who.int/publications/2010/9789241599085_eng.pdf (accessed 23 December 2013).
20. Lilian RR, Kalk E, Technau K-G, Sherman GG. Birth diagnosis of HIV infection on infants to reduce infant mortality and monitor for elimination of mother-to-child transmission. Pediatr Infect Dis J 2013;32(10):1080-1085. [http://dx.doi.org/10.1097/INF.0b013e318290622e]
21. Shapiro RL, Holland DT, Capparelli E, et al. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis 2005;192(5):720-727. [http://dx.doi. org/10.1086/432483]
22. Goga AE, Dinh T-H, Jackson DJ, for the SAPMTCTE study group. Evaluation of the effectiveness of the national prevention of mother-to-child transmission (PMTCT) programme measured at six weeks postpartum in South Africa, 2010. South African Medical Research Council, National Department of Health of South Africa and PEPFAR/US Centers for Disease Control and Prevention, 2012. http://www.hst.org.za/ publications/evaluation-effectiveness-national-prevention-mother-child-transmission-pmtct-programme-(accessed 24 June 2013).
23. Roche® COBAS® AmpliPrep/COBAS® TaqMan HIV-1 Qualitative Test, version 2.0 [package insert]. Branchburg, NJ: Roche, 2013.